Panel discussions include: how to assure clinical quality during and post-COVID, the shift to virtual trials, and how COVID-19 has impacted clinical risk management at companies with limited resources.
Featured Speakers
Federico Feldstein, J.D.
Vice President, Head of BioResearch Quality and Compliance JOHNSON & JOHNSON
Kathy Goin
Vice President, Development Operations PALVELLA THERAPEUTICS, INC.
David Fryrear
Senior Vice President, Head of Clinical & Research Quality Assurance ASTELLAS
Michele Weitz
Senior Director, Clinical Standards and Innovation CLOVIS ONCOLOGY
